Drugs / Tissucol
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01306370 | Jun 2010 → Oct 2011 | arthropathy | Sant Pau Research Institute | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01127984 | Dec 2009 → Jan 2011 | — | Careggi Hospital | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01003613 Comparator | Feb 2009 → Jul 2011 | pterygium | Gildasio Castello de Almeida Junior | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tissucol | “Tissucol® (fibrin glue)” NCT01306370 ↗ |
| Known as | Tissucol-Baxter | “fibrin sealant (Tissucol-Baxter)” NCT01127984 ↗ |
| Modality | Protein / enzyme biologic | “fibrin sealant (Tissucol-Baxter)” NCT01127984 ↗ |
| Route | Other | “local application of tissucol in the pocket of pacemaker/ICD” NCT01127984 ↗ |